The Clorox Company (CLX) Stock: Price, Forecast & Analyst Target
The Clorox Company (CLX) — MoonshotScore 49/100 (Fair band), calculated Oct 4, 2026. Price $80.41 (-0.30%), as of the Oct 2, 2026 trading session; market cap $9.72B. Expected results Nov 3, 2026.
Educational signal · not a buy or sell recommendation · How to read this
The Clorox Company · CLX · NYSE · Consumer Defensive · Household & Personal Products
Research dated 2026-09-13: Clorox sells branded cleaning, household, food, personal-care, filtration and wellness products through retail, professional and international channels. Its case rests on whether brand investment can revive sales and margins strongly enough to support cash generation while debt remains heavy.
Price as of Oct 2, 2026
Key Statistics
MoonshotScore v2 · The Clorox Company (CLX)
FairWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
A fragile balance sheet, weak growth and a full valuation. Business Quality: Solid; Financial Safety: Fragile; Valuation: Rich; Growth Durability: Fading; Momentum: Slipping.
- quarterly revenue $1.95B (Q4 FY2026, quarter ended Jun 2026)
- EPS beat 6 of 8
- expected results Nov 3, 2026
Holding back: balance-sheet strain, a rich price, weak price trend
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 49 | Fair | |
| 49 | Fair | |
| 49 | Fair | |
| 49 | Fair | |
| 49 | Fair | |
| 49 | Fair |
The score was 49 in the stored Oct 3, 2026 snapshot and remains 49 in the current publication computed Oct 4, 2026 (0); the largest pillar moves were Growth Durability +1; the pillar moves offset under the sector-relative weighting, so the headline score is unchanged.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · Educational signal · not a buy or sell recommendation · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $80.41 | |
| Change on the day | -0.30% | |
| 52-week range | $79.12–$128.90 | |
| Market capitalisation | $9.72B | |
| Price / earnings (trailing) | 16.68 | |
| Shares traded on the day | 2.28M | |
| Beta (volatility vs the S&P 500) | 0.54 |
Price & events
Point at or tab to any week for its close.
Other perspectives
Council score for The Clorox Company (CLX): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
5 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Oct 3, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Oct 5, 2026, except a card that shows its own read date.
Watch the CLX film — every key number, told as a short cinematic story
~2 min · open the film
What is The Clorox Company (CLX), and what does it report?
Short answer · as of
Clorox is not merely a bleach or disinfectant company. Its portfolio spans home cleaning, professional sanitation, cat litter, bags and wraps, charcoal, dressings and sauces, natural personal care, water filtration, and supplements, making consumer usage and retailer demand across distinct categories the underlying units of demand.
Research dated 2026-09-13.
Clorox is not merely a bleach or disinfectant company. Its portfolio spans home cleaning, professional sanitation, cat litter, bags and wraps, charcoal, dressings and sauces, natural personal care, water filtration, and supplements, making consumer usage and retailer demand across distinct categories the underlying units of demand.
Reported revenue is divided among Health and Wellness, Household, Lifestyle and International. Health and Wellness contributes the largest share, while the remaining segments expose Clorox to different purchase occasions, channels and category pressures.
What do the latest results show for The Clorox Company (CLX)?
Short answer · as of
The most recent reported quarter, Q4 FY2026, carried revenue of $1.95B.
Research dated 2026-09-13.
The latest annual results show lower revenue and profit than the prior year. The latest reported quarter also produced weaker sales, gross profit and earnings than the comparable period, despite revenue and adjusted earnings coming in above analyst expectations.
Operating cash flow recovered sharply after turning negative in the preceding quarter, but the sequence remains uneven. Management expects stronger gross margin by the end of the current fiscal year without fully recovering the full-year result, while planned spending on product superiority could support demand at the cost of near-term resources.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Jun 30, 2026 | Not available | Not available | Not available | Not available |
| Mar 31, 2026 | Not available | Not available | Not available | Not available |
| Dec 31, 2025 | Not available | Not available | Not available | Not available |
| Sep 30, 2025 | Not available | Not available | Not available | Not available |
USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 FY2026 | $1.95B | $163M | $1.33 (diluted) |
| Q3 FY2026 | $1.67B | $187M | $1.54 (diluted) |
| Q2 FY2026 | $1.67B | $157M | $1.29 (diluted) |
| Q1 FY2026 | $1.43B | $80M | $0.65 (diluted) |
What are the financial strengths and risks for The Clorox Company (CLX)?
Short answer
Cash and short-term investments were $0.00 at the Jun 30, 2026 balance-sheet date. This figure does not establish a cash runway.
Research dated 2026-09-13.
Clorox remains profitable and generates operating cash, but liquidity offers little protection against its debt load. Cash sits far below total debt, short-term liquidity ratios are below full coverage, and the cash balance ended below where it began across the reported window.
The main financial risk is that weak sales or incomplete gross-margin recovery reduces the cash available for capital spending, dividends and debt service. Recent cash generation and continued dividend payments show that the business still produces distributable cash, yet the volatile quarterly pattern makes sustained conversion more important than any isolated period.
What should you watch next at The Clorox Company (CLX)?
Short answer · as of
The next earnings report is expected on Nov 3, 2026.
Research dated 2026-09-13.
Watch whether sales return to growth across the branded portfolio and whether gross profit improves alongside them. A healthier result would combine revenue progress, stronger gross margin and dependable operating cash flow rather than relying on earnings performance alone.
Management has set expectations for stronger cash generation, a better exit gross margin and eventual revenue benefits from current initiatives. The scheduled earnings release should reveal whether those claims are beginning to appear while analyst estimates assume continuing revenue and earnings growth over the following years.
Cash deserves separate attention after its sharp rise and subsequent fall. Stabilization alongside positive operating cash flow would strengthen the financial picture; renewed cash contraction without better sales or margins would increase the weight of the debt burden.
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
Checked against the records this page reads, on the dates shown above.
How does The Clorox Company compare with its peers?
Short answer
The Clorox Company's score ranks 13th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-13.
Clorox differs from a narrowly focused cleaning-products business because its brands serve household maintenance, pet care, grilling, food, personal care, filtration and wellness demand. That breadth diversifies purchase occasions, but it also means consolidated performance can reflect unrelated category movements.
Its reporting structure makes the mix visible: Health and Wellness is the largest segment, while Household, Lifestyle and International remain substantial contributors. Clorox therefore combines domestic branded staples with professional products and an international portfolio rather than depending on a single product family or sales channel.
| Company | Price | Market value | Score |
|---|---|---|---|
| $78.32 Oct 2, 2026 | $1.82B | 92 5-pillar Oct 4, 2026 | |
| $113.95 Oct 2, 2026 | $3.65B | 91 5-pillar Oct 4, 2026 | |
| $84.26 Oct 2, 2026 | $67.4B | 88 5-pillar Oct 4, 2026 | |
| $192.04 Oct 2, 2026 | $15.1B | 81 5-pillar Oct 4, 2026 | |
| $94.31 Oct 2, 2026 | $22.4B | 77 5-pillar Oct 4, 2026 | |
| $104.68 Oct 2, 2026 | $6.17B | 72 5-pillar Oct 4, 2026 | |
| $17.20 Oct 2, 2026 | $33.0B | 71 5-pillar Oct 4, 2026 | |
| $44.67 Oct 2, 2026 | $12.0B | 64 5-pillar Oct 4, 2026 | |
| $94.36 Oct 2, 2026 | $31.3B | 64 5-pillar Oct 4, 2026 | |
| $91.97 Oct 2, 2026 | $33.3B | 64 5-pillar Oct 4, 2026 | |
| $93.85 Oct 2, 2026 | $14.7B | 63 5-pillar Oct 4, 2026 | |
| $61.97 Oct 2, 2026 | $13.0B | 57 5-pillar Oct 4, 2026 | |
| The Clorox Company (CLX) — this page | $80.41 | $9.72B | 49 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $83.00 – $127.00
- Consensus target
- $100.11
- Median target
- $98.00
Consensus record · Captured .
Measured against a quoted price of $80.41 (as of Oct 2, 2026).
Insider activity
Form 4 records via FMP · Of the newest 60 records, those within the last 180 days, newest dated Sep 30, 2026
- Transactions
- 34
- Identified insiders
- 12
- Purchases
- 1
- Sales
- 0
- Other transactions
- 33
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
What has been published about The Clorox Company (CLX)?
What Investors Ask About The Clorox Company (CLX) — Consumer Defensive
Research dated 2026-09-13; the answers below are from that research, and the full attribution is under Sources. The last 3 questions are answered from this page's own dated data, not from the research.
Is Clorox mainly a bleach and disinfectant company?
Cleaning is central, but Clorox also sells cat litter, food-storage products, charcoal, dressings, personal care, filtration products and supplements. Its results reflect this broader collection of branded household and wellness categories.
Why does Health and Wellness matter so much to Clorox?
Health and Wellness is Clorox’s largest reported segment and includes consumer cleaning, professional sanitation and supplements. Its scale means weakness or recovery there can materially shape consolidated sales.
Can Clorox support its dividend while carrying heavy debt?
Clorox is profitable and continues to generate operating cash, but cash is small relative to debt and quarterly conversion has been uneven. Dividend durability therefore depends on sustained cash generation rather than the balance-sheet cash reserve.
What would confirm Clorox gross-margin recovery?
Confirmation would require gross profit to strengthen across upcoming results while revenue stabilizes and operating cash flow remains positive. Management expects a stronger exit margin but does not expect full-year recovery, making the progression more informative than an isolated quarter.
What is the CLX stock price today?
The last price recorded on this page for The Clorox Company (CLX) is $80.41, as of the Oct 2, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the CLX price target?
The analyst consensus price target for The Clorox Company (CLX) is $100.11 (range $83.00 to $127.00, median $98.00), per FMP data captured Oct 4, 2026. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
When are CLX's next earnings?
The next earnings date listed on this page for The Clorox Company (CLX) is Nov 3, 2026. Companies sometimes move report dates, so the company's own announcement is the final word on timing.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are shown with each answer. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (26 figures)
The 26 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
OFFICIAL — 1 fact from SEC filings and earnings calls
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
id.hq | SEC filing business address | THE Clorox Company, 1221 Broadway, Oakland, CA, 94612-1888 | OFFICIAL | SEC EDGAR filer business address — The SEC filer business address. Our market-data provider separately lists "1221 Broadway, Oakland, CA, 94612-1888, US". |
FMP — 21 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $80.41 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-04T20:54:40.633Z. | |
px.change | Change on the day | -0.30% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalization | $9.72B | FMP | Financial Modeling Prep (FMP) quote — Provider market cap uses the share class it prices; a company with more than one class may show a larger total elsewhere. Market cap record date: 2026-10-04. Source capture time was not supplied. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
px.change_abs | Change on the day, in dollars | −$0.24 | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q4 FY2026 | $1.95B | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
px.range52 | 52-week range | $79.12–$128.90 | FMP | Financial Modeling Prep (FMP) quote | |
px.pe | Price / earnings (trailing) | 16.68 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 2.28M | FMP | Financial Modeling Prep (FMP) · quote | |
px.beta | Beta | 0.54 | FMP | Financial Modeling Prep (FMP) company profile | |
id.ceo | Chief executive | Linda J. Rendle | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it. | |
id.employees | Employees | 9,200 | FMP | Financial Modeling Prep (FMP) company profile | |
fin.annual | Revenue and net result by fiscal year | 5 fiscal years, FY1970 through FY2026: FY1970 revenue $0.00, net result $0.00; FY2023 revenue $0.00, net result $0.00; FY2024 revenue $0.00, net result $0.00; FY2025 revenue $0.00, net result $0.00; FY2026 revenue $0.00, net result $0.00 | FMP | Financial Modeling Prep (FMP), from the company's 10-K income statements | |
fin.gross_margin | Gross margin (trailing twelve months) | 42.3% | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero. | |
fin.q_table | Quarterly income statement | 4 quarters through Q4 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
fin.cash_investments | Cash and short-term investments | $0.00 | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review. The market-value ratio is undefined when the reported amount is zero. | |
fin.total_debt | Total debt | $0.00 | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | |
fin.price_to_book | Price to book value | 108.08× | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero. | |
earn.pt_range | Analyst price target, low to high | $83.00 – $127.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied | |
earn.pt_consensus | Consensus analyst price target | $100.11 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied | |
earn.pt_median | Median analyst price target | $98.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied | |
own.insiders | Insider transactions via FMP | 34 transactions · 1 purchases, 0 sales, 33 other transactions · 12 identified insiders · of the newest 60 records, those within the last 180 days, newest dated Sep 30, 2026 | FMP | Financial Modeling Prep (FMP), carrying Form 4 transaction records — Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent. |
UNRECORDED — 2 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
earn.next | Next earnings date | Nov 3, 2026 | UNRECORDED | Stored earnings-calendar observation — Captured 2026-09-30 | |
earn.history | Reported versus estimated, recent quarters | EPS beat 6 of 8 | UNRECORDED | Stored earnings-history observation — Captured 2026-10-04 |
OURS — 2 facts from Stock Expert AI's own score and rank
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
ours.moonshot | MoonshotScore v2 | 49 of 100 · Fair · pillars 66 / 18 / 31 / 37 / 31 | OURS | Stock Expert AI MoonshotScore v2 engine | |
ours.moonshot_change | MoonshotScore movement | 49 (stored snapshot Oct 3, 2026) → 49 (current publication computed Oct 4, 2026) (0) | OURS | Stock Expert AI current score publication and immutable score snapshots |
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources used for research written 2026-09-13
Historical evidence preserved with this analysis. Current figures are listed separately above.
| Evidence | Captured value | Source date | Source type | Source |
|---|---|---|---|---|
| Business description | The Clorox Company is a global manufacturer and marketer of both consumer and professional products, operating through four distinct segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness division offers a range of cleaning solutions, including laundry additives and home care items under brand names such as Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409. It also supplies professional cleaning and disinfecting products via the CloroxPro and Clorox Healthcare brands, alongside professional food service goods from Hidden Valley. Additionally, this segment provides vitamins, minerals, and supplements (VMS) within the United States, marketed under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light labels. Dedicated to the U.S. market, the Household segment features cat litter products from Fresh Step and Scoop Away, food storage bags and wraps under the Glad brand, and grilling essentials like Kingsford charcoal. The Lifestyle segment, also primarily serving the U.S., encompasses dressings, dips, seasonings, and sauces, predominantly from Hidden Valley; natural personal care items offered by Burt's Bees; and water-filtration systems from Brita. Internationally, the International segment distributes a broad portfolio of products including laundry additives, home care items, water-filtration systems, digestive health products, grilling supplies, cat litter, various food items, bags and wraps, natural personal care products, and professional cleaning and disinfecting solutions. Key international brands include Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean, and Burt's Bees. Clorox's extensive product line reaches customers through a diverse array of channels. These include major retailers, grocery stores, warehouse clubs, discount outlets, home hardware centers, pharmacies, pet stores, military exchanges, both company-owned and third-party e-commerce platforms, distributors, and a direct sales force. Established in 1913, the company's corporate headquarters are situated in Oakland, California. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) company profile |
| Revenue by segment | Household: $1.79B; Lifestyle: $1.12B; International: $1.11B; Health and Wellness: $2.70B | 2026-06-30 | FMP | Financial Modeling Prep (FMP) revenue segmentation, from the company's 10-K |
| Annual revenue and net result (USD millions) | Captured record · 5 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's 10-K income statements |
| Cash, investments and debt | Total debt: $5.52B; Liquidity basis: cash and short-term investments; Total liabilities: $7.54B; Cash and short-term investments: $143.00M; Cash and investments: $143.00M; Long-term investments: $0; Long-term investments classification: unclassified Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's balance sheet |
| Management outlook — dated call excerpts | Captured record · 4 entries
Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording. | 2026-08-03 | OFFICIAL | Company earnings call, transcript via Financial Modeling Prep (FMP) |
| Sector / industry (provider taxonomy) | Consumer Defensive / Household & Personal Products The company's SEC filings classify it under SIC 2842 — Specialty Cleaning, Polishing and Sanitation Preparations. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) company profile |
| Quarterly income statement (USD thousands) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements |
| Operating cash flow by quarter (USD millions) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements |
| Reported versus estimated, last 8 quarters | Captured record · 8 entries
| 2026-08-03 | FMP | Financial Modeling Prep (FMP) earnings |
| Most recent periodic reports | 2026-08-07 | OFFICIAL | SEC EDGAR filer submissions | |
| Cash and investment components | Total basis: cash short and long-term investments; Total: $143.00M; Cash and short-term investments: $143.00M; Long-term investments: $0; Long-term investments classification: unclassified Sums the balance sheet's cash and short-term investments with its long-term investments.; The long-term investment field does not establish marketability; the sum is not a measure of available liquidity.; These provider fields do not establish investment access restrictions or explain differences from third-party cash figures. | 2026-06-30 | COMPUTED | Computed from the balance sheet |
| Cash and short-term investments over time (USD millions) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's quarterly balance sheets |
| Cash decline over the reported window | To: 2026-06-30; From: 2024-09-30; Periods: 7; Cash basis: cash and short-term investments; Closing balance: $143.00M; Decline: $135.00M; Opening balance: $278.00M; Average change per period: $19.30M Change in cash, cash equivalents and short-term investments between the 2024-09-30 and 2026-06-30 balance sheets.; This is a balance change, not operating burn: financing and investing move it too.; Averaged over 7 reporting periods of unequal length. | 2026-06-30 | COMPUTED | Computed from reported balances |
| Cash against market value | As of: 2026-06-30; Cash basis: cash and short-term investments; Net cash: -$5.38B; Total debt: $5.52B; Cash and investments: $143.00M Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. Cash is the latest reported cash and short-term investment balance; long-term investments are excluded. Market capitalization is the latest provider value.; The reported balance does not establish unrestricted availability or liquidation value.; The two are measured on different dates — the balance sheet is a quarter-end, the market cap is a recent close.; Debt is total debt as reported, including operating lease liabilities where the filer includes them. | 2026-06-30 | COMPUTED | Computed from the balance sheet and the latest market capitalization |
| Trailing twelve-month ratio set | Quick ratio: 0.38; Current ratio: 0.66; Debt to equity: 61.33; Net margin: 8.7%; Gross margin: 42.3%; Operating margin: 24.7%; Return on assets: 7.5% Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. A ratio our provider could not compute is absent rather than shown as zero. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm |
| Distress and quality screens | Altman Z-score: 2.02; Piotroski F-score: 5 Altman Z below 1.8 is the conventional distress zone. The screen is built for manufacturers and industrials; for banks, insurers and property companies it is not a meaningful reading. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) financial scores |
| Recent dividends paid | Captured record · 4 entries
Declared amounts per share on their ex-dates. A single payment does not establish an annual rate, and a special dividend is not separated here. | 2026-08-12 | FMP | Financial Modeling Prep (FMP) dividend history |
| Dividends per share, last 12 months | $4.97 Sum of 4 payments with an ex-date in the 365 days to 2026-09-13. A past window, not a declared annual rate; a special dividend inside it is included. | 2026-08-12 | FMP | Financial Modeling Prep (FMP) dividend history |
| Dividend yield, last 12 months | 5.66% Payments made in the last 12 months divided by the close this page was built from. Backward-looking; it is not a forecast and the company has not declared it as a rate. | 2026-08-12 | FMP | Financial Modeling Prep (FMP) dividend history and quote |
| Next earnings report | Date: 2026-11-03; EPS estimate: $1.11 per share; Revenue estimate: $1.88B The date is our provider's estimate until the company confirms it. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) earnings calendar |
| Analyst revenue and earnings estimates (average) | Captured record · 4 entries
| 2026-09-13 | FMP | Financial Modeling Prep (FMP) analyst estimates |
Data provided for informational purposes only.
ETFs that hold CLX
Funds in our ETF coverage that list CLX among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.